Cell No. : Cell Name
HPS3074 :
update : 2019/09/06
|
Comment | Currently not ready. Human iPS cell line derived from a healthy individual. Healthy family of NGLY1 deficiency patient (HPS3054〜HPS3059, HPS3060〜HPS3065). |
Comment from the depositor | Falimy control iPS cels. iPS cells were established from the peripheral blood mononuclear cells of healthy family of NGLY1 deficiency patient using episomal vectors encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, mp53DD and EBNA1. |
Terms and conditions | |
Remarks | |
Order Form |
|
Regarding MTA between user institutions and RIKEN BRC, there are two kinds of MTA, not-for-profit academic purpose (C-XXXX) and for-profit research purpose (C-XXXXp) , depending on the sort of user institutions and the purposes of use. Please use an appropriate MTA(to see). In relation to commercial use and use for patent filing, first of all Please contact RIKEN BRC (cellbank.brc@riken.jp).
|
|
Basic information
|
Expected time |
Upon a request we will start preparation. Contact us: cellips.brc@riken.jp
|
Reference information |
Reference |
0
|
User's Publication |
0
|